Form 4: MicroStrategy CEO Le Phong Acquires Series A Preferred Stock
SEC Form 4 Filing
MicroStrategy's CEO, Le Phong, reports the acquisition of 6,000 shares of Series A Perpetual Strife Preferred Stock at $85 per share through a directed share program.
Summary
- Le Phong, the President and CEO of MicroStrategy, has reported changes in beneficial ownership to the SEC.
- On March 20, 2025, Phong acquired 6,000 shares of Series A Perpetual Strife Preferred Stock at a price of $85 per share.
- This purchase was made through a directed share program related to MicroStrategy's public offering of the Series A Preferred Stock.
- Phong also directly owns 14,126 shares of Class A Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard SEC filing reporting a transaction. The CEO's purchase could be seen as a positive signal, but it's not overwhelmingly so.
Positives
- The CEO's investment in the company's preferred stock could signal confidence in MicroStrategy's prospects.
Industry Context
This filing reflects insider activity related to a recent public offering. Insider transactions are closely watched by investors for signals about a company's prospects.
Stakeholder Impact
- Shareholders may view the CEO's purchase of preferred stock as a positive sign of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/20/2025 | Date of transaction: Le Phong acquired Series A Perpetual Strife Preferred Stock. |
| 03/24/2025 | Date of signature on the report. |
Keywords
MicroStrategy, Le Phong, Series A Perpetual Strife Preferred Stock, Beneficial Ownership, SEC Form 4, Directed Share Program, MSTR, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.